Privia Health Group (PRVA) Competitors $24.05 -0.05 (-0.21%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRVA vs. HIMS, OPCH, GH, RDNT, BTSG, SHC, SGRY, CON, LFST, and WGSShould you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and GeneDx (WGS). These companies are all part of the "healthcare" industry. Privia Health Group vs. Hims & Hers Health Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent LifeStance Health Group GeneDx Hims & Hers Health (NYSE:HIMS) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, community ranking, dividends, risk and analyst recommendations. Is HIMS or PRVA more profitable? Hims & Hers Health has a net margin of 8.19% compared to Privia Health Group's net margin of 0.75%. Hims & Hers Health's return on equity of 10.97% beat Privia Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Privia Health Group 0.75%2.02%1.21% Do insiders and institutionals have more ownership in HIMS or PRVA? 63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 14.2% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community favor HIMS or PRVA? Privia Health Group received 31 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 75.51% of users gave Privia Health Group an outperform vote while only 36.44% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes4336.44% Underperform Votes7563.56% Privia Health GroupOutperform Votes7475.51% Underperform Votes2424.49% Which has better valuation and earnings, HIMS or PRVA? Privia Health Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B4.24-$23.55M$0.5452.24Privia Health Group$1.74B1.68$23.08M$0.11218.64 Does the media prefer HIMS or PRVA? In the previous week, Hims & Hers Health had 11 more articles in the media than Privia Health Group. MarketBeat recorded 28 mentions for Hims & Hers Health and 17 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.91 beat Hims & Hers Health's score of 0.77 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 14 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 5 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend HIMS or PRVA? Hims & Hers Health presently has a consensus target price of $38.25, indicating a potential upside of 35.59%. Privia Health Group has a consensus target price of $26.87, indicating a potential upside of 11.71%. Given Hims & Hers Health's higher probable upside, equities research analysts plainly believe Hims & Hers Health is more favorable than Privia Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21Privia Health Group 0 Sell rating(s) 1 Hold rating(s) 13 Buy rating(s) 2 Strong Buy rating(s) 3.06 Which has more risk & volatility, HIMS or PRVA? Hims & Hers Health has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. SummaryPrivia Health Group beats Hims & Hers Health on 10 of the 19 factors compared between the two stocks. Remove Ads Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRVA vs. The Competition Export to ExcelMetricPrivia Health GroupHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.92B$1.04B$5.35B$7.58BDividend YieldN/A2.62%5.11%4.33%P/E Ratio240.5251.1121.6717.78Price / Sales1.683.71376.3294.47Price / Cash98.2426.1438.1534.64Price / Book4.684.236.443.99Net Income$23.08M-$5.50M$3.20B$247.24M7 Day Performance10.63%310.99%9.00%8.29%1 Month Performance1.26%295.65%-6.10%-5.37%1 Year Performance31.06%202.85%10.71%-0.24% Privia Health Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRVAPrivia Health Group3.7775 of 5 stars$24.05-0.2%$26.87+11.7%+29.7%$2.92B$1.74B240.52810HIMSHims & Hers Health3.5748 of 5 stars$27.71+6.6%$37.31+34.7%+102.1%$6.16B$1.48B62.97650Gap UpOPCHOption Care Health3.1288 of 5 stars$32.87-2.0%$33.00+0.4%+4.7%$5.40B$5.00B27.625,600Short Interest ↑Positive NewsGHGuardant Health3.6834 of 5 stars$41.78+3.0%$48.95+17.2%+147.3%$5.16B$739.02M-11.741,790Gap UpRDNTRadNet3.8273 of 5 stars$49.29+1.2%$73.25+48.6%+10.0%$3.65B$1.83B-704.048,970Analyst ForecastNews CoveragePositive NewsGap UpHigh Trading VolumeBTSGBrightSpring Health Services2.8945 of 5 stars$17.28+0.8%$21.67+25.4%+70.1%$3.02B$11.27B-66.4635,000Gap DownSHCSotera Health2.3755 of 5 stars$10.23-1.1%$16.00+56.4%-5.9%$2.90B$1.10B40.923,000Gap DownSGRYSurgery Partners2.8591 of 5 stars$20.51-2.8%$36.63+78.6%-19.0%$2.62B$3.11B-42.7313,500Positive NewsGap DownCONConcentra Group Holdings ParentN/A$20.19-2.1%$28.50+41.2%N/A$2.57B$1.90B13.3711,000Positive NewsGap DownLFSTLifeStance Health Group1.8866 of 5 stars$6.51-2.0%$8.50+30.6%+13.2%$2.50B$1.25B-25.046,640WGSGeneDx1.7888 of 5 stars$84.77+5.9%$72.33-14.7%+950.3%$2.38B$305.45M-43.251,200Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies HIMS Competitors OPCH Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors CON Competitors LFST Competitors WGS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRVA) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
